Jan-Olav Henck, PhD,
chief scientific officer
Jan-Olav Henck, PhD, chief scientific officer at Aptuit, discusses strategies and considerations in polymorph screening with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).
Keith Moore, vice-president of analytical services, Metrics Contract Services discusses gains use in dissolution testing.
Today’s analytical laboratory equipment reflects the realities of downsizing, outsourcing, and the need for speed.
Heightened global uncertainty could slow bio/pharma development activity.
There was scant praise from the medical community for the eighth and final budget plan from the Obama administration.
The agency prepares a plan to implement new packaging safety features.
FDA staff said Celltrion’s biosimilar form of infliximab is highly similar to Remicade.
Ingredients Insider Cynthia ChallenerFaster, Cheaper, and Greener